The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Xonvea 10 mg/10 mg gastro-resistant tablets

Alliance Pharma (Ireland) LimitedPA2325/016/001

Main Information

Trade NameXonvea 10 mg/10 mg gastro-resistant tablets
Active SubstancesDoxylamine hydrogen succinate
Pyridoxine Hydrochloride
Dosage FormGastro-resistant tablet
Licence HolderAlliance Pharma (Ireland) Limited
Licence NumberPA2325/016/001

Group Information

ATC CodeR06AA59 doxylamine, combinations


License statusAuthorised
Licence Issued05/04/2019
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportPDF Version
« Back